Towards Wnt inhibition without prohibitive toxicity

Towards Wnt inhibition without prohibitive toxicity

Wnt fuels cancer growth and drug resistance in millions of patients each year - yet any attempts to drug it have been blocked by toxicity.

Wnt fuels cancer growth and drug resistance in millions of patients each year - yet any attempts to drug it have been blocked by toxicity.

The Unmet Need

Wnt drives cancer drug resistance

For millions of patients annually, Wnt drives cancer growth and drug resistance

Implicated across all major solid tumors

The Unmet Need

Wnt drives cancer drug resistance

For millions of patients annually, Wnt drives cancer growth and drug resistance

Implicated across all major solid tumors

The Problem

Broad Inhibition is overly toxic

No approved Wnt inhibitor drug

Pharma giants tried for 30+ Years

Described as undruggable

The Problem

Broad Inhibition is overly toxic

No approved Wnt inhibitor drug

Pharma giants tried for 30+ Years

Described as undruggable

The Innovation

Receptor Selective Inhibition

Targeting the specific Wnt receptor a tumor relies on for survival and resistance

Healthy tissue can rely on other receptors

The Innovation

Receptor Selective Inhibition

Targeting the specific Wnt receptor a tumor relies on for survival and resistance

Healthy tissue can rely on other receptors

The Opportunity

Engineered For Tolerability

First-in-class Wnt inhibitor molecule with a wide theraupetic window

Mono- and combination therapy potential

The Opportunity

Engineered For Tolerability

First-in-class Wnt inhibitor molecule with a wide theraupetic window

Mono- and combination therapy potential

Explore our preclinical data

Explore our

preclinical data

Book a call to meet a founder, learn more about our data, and discuss what selective Wnt inhibition could mean for oncology.

Book a call to meet a founder, learn more about our data, and discuss what selective Wnt inhibition could mean for oncology.

Phase 2

Phase 2

Phase 1

Phase 1

Pre-Clinical

Pre-Clinical

Research

Research

The Team

The Team

Pioneered by scientists with two decades and 8,000+ citations in Wnt research. Backed by business veterans.

Pioneered by scientists with two decades and 8,000+ citations in Wnt research. Backed by business veterans.

Precision medicine company advancing selective Frizzled (FZD) inhibitors to address dysregulated WNT signaling in cancer and drug-resistant diseases.

All Rights Reserved

Precision medicine company advancing selective Frizzled (FZD) inhibitors to address dysregulated WNT signaling in cancer and drug-resistant diseases.

All Rights Reserved

Precision medicine company advancing selective Frizzled (FZD) inhibitors to address dysregulated WNT signaling in cancer and drug-resistant diseases.

All Rights Reserved